Pharma.Aero announces expanded Advisory Board for 2025,  bringing together experts from airports, airlines, freight forwarders, ground handlers, transporters, and three global pharmaceutical manufacturers. For the first time, the sea freight is represented, as the global collaborative platform expanded its scope in 2024, from exclusively air freight to multimodal.

Members of the 2025 Advisory Board

Airports

Milton De La Paz
Vice President, Airline Relations & Cargo
Dallas Fort Worth International Airport

Airlines

Miguel Rodriguez
Head of Cargo Products
Qatar Airways Cargo

Freight Forwarders

Ground Handlers

Kenneth Kallstrom
Vice President, Global Key Accounts Healthcare Commercial Group
DSV

Barry Shields
Manager Cargo Operations
dnata

Transporters

Pharma Manufacturers

Can Pekerbas
Director, APAC & Speciality Logistics Transport Solutions Operations Lead
Pfizer Global Supply – Global Logistics and Network Services

Victoria Wilmore
Director, External Supply Services MTO Digital Operations & Technical Services
J&J Innovative Medicine

Pharma Manufacturers

Milton De La Paz
Vice President, Airline Relations & Cargo
Dallas Fort Worth International Airport

Ruud van der Geer
Assoc. Director, Logistic Solutions & EMEA Product Handling
Global Deliver Strategy Team (GDST)
MSD

Pharma.Aero has established the Advisory Board in 2021, bringing together industry experts among its Full Members, each representing a different segment of the air cargo supply chain: Airlines, Airports, Freight Forwarders and Ground Handlers. In 2023, the Advisory Board expanded to include representatives of the pharmaceutical manufacturing industry, with Pfizer getting on board first. In November, Novartis joined the Life Science Advisory Manufacturers Platform and was elected to the Advisory Board.

Miguel Rodriguez, Qatar Airways Cargo: “I am deeply honored to be nominated to represent Qatar Airways on Pharma.aero’s Advisory Board for 2025. Over the years, I have had the privilege of witnessing the incredible impact this organization has in uniting various stakeholders in the pharmaceutical supply chain. Contributing to numerous projects aimed at improving processes and enhancing the industry’s overall knowledge of air cargo operations has been truly rewarding. This year, I am excited to continue making meaningful contributions across different areas of work, further solidifying the organization, and fostering the development of innovative solutions. My goal is to support in anticipating industry needs and bring the valuable lessons learned back to my team at Qatar Airways. I look forward to another year of collaboration and growth with Pharma.Aero.”

Kenneth Kallstrom, DSV: “As a member of the Pharma.Aero Advisory Board, I look forward to leveraging my extensive healthcare logistics experience to support the organization, with a strong focus on innovation, collaboration, and a global perspective.”

Barry Shields, dnata: “I am honoured to join the Pharma.Aero Advisory Board and contribute to its mission of fostering collaboration and innovation in global pharmaceutical logistics. Bringing together the academic world, pharmaceutical manufacturers, and business logistics stakeholders from all around the globe. 

I look forward to participating in strategic projects that address the evolving demands of the pharma logistics chain. Leveraging my experience in cargo handling operations and cold chain logistics, I aim to support the development of efficient, compliant, and sustainable solutions that enhance the reliability of global healthcare supply chains.

Pharma.Aero shares dnata’s commitment to service excellence, and I look forward to aligning these values with the goals of Pharma.Aero to drive further innovation and advancements within the pharmaceutical logistics sector.”

Michiel Heller, Transpharma International: “I’ve been in contact with Pharma.Aero little over a year now. This was after the acquisition of Ivemar who was already a member. During that time I’ve seen the good, and innovating work that Pharma.Aero brings to healthcare supply chains. And that is very well inline with the values of our company. I’m exited to be part of the advisory board and in the end to be part of quality of life for the people around us.”

Can Pekerbas. Pfizer: “I am deeply honored to be part of this collaboration initiative. We have diverse roles in different supply chain organizations but we have the same mission: delivering medicines and therapies for patients globally.  I appreciate the Pharma.Aero platform for uniting all stakeholders under a shared vision which will unlock opportunities for patients globally.”

Victoria Wilmore, J&J Innovative Medicine: “We can do more together!  I wholeheartedly believe this and that is why I am both thrilled and deeply honored to join the Pharma.Aero Advisory Board.  With the ever-changing air cargo landscape coupled with revolutionary new therapies that life science manufacturers are commercializing, there has never been a stronger call to action than now.  Working across traditional boundaries, sharing knowledge, and challenging the status quo is how we are going to reach more patients globally.  It is a privilege to contribute to such a meaningful mission and I am eager to collaborate with fellow experts to improve and innovate how pharmaceutical logistics contribute to the wider pursuit of a healthier world.”

Ruud van der Geer, MSD: “I would like to thank to the Pharma.Aero community for allowing me to be an advocate for the Life Science and MedTech industry. Through creative thought leadership and collaboration, I plan to further focus on our community challenges regarding end-to-end visibility, supply chain resilience and sustainability, among others.”